Inject while the area is still numb
A large study of privately insured adults and Medicare beneficiaries published in JAMA Network Open showed that annual health spending increased by $326 per person for each percentage-point increase in body mass index (BMI) when obesity was left untreated
155 However, whether this can be extrapolated to other CMRFs, and whether there is a pharmacoeconomic imperative, needs further clarification
In clinical trials, participants taking the highest dose of tirzepatide lost an average of 22.5% of their body weight over 72 weeks
Related solutions Grow your brand, now and through patent expiry Simplify compliance, save your bottom line Gain high value access and increase the profitability of your brands We empower life sciences with connected intelligence, transforming data into actionable insights for smarter decisions and better patient outcomes.
Canada is anticipated to grow at 17.2% as provincial rules influence service localization